rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

Avalyn Pharma Inc.

AVLN · Nasdaq

Health CareBiotechnology

We hold no 150-day reading for AVLN yet: it needs about 200 sessions of history. Biotechnology: 15% of its 561 stocks in an uptrend (−17 points in four weeks); Health Care: 25% (−11 points in four weeks).

SEC filings

Statistics

Rotation
not in the set
Weeks in an uptrend
—
Industry in uptrend
15% -17 in 4 wk
Insider buys, 12 months
$50.0M
Insider sales, 12 months
$0
Officials’ trades on record
0
Institutions holding
90

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 0 of 0 weeks.

17 Apr – 16 Oct
16%28%39%Apr 26Jun 26Jul 26Sep 26Oct 26

Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026
$0$48.2MNov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months4
Sale orders, 12 months0
Buyers · sellers4 · 0
WhoDidSharesTraded
Sr One Capital Management, Llc10% ownerbought277,778at $18.001 May 2026filed 1 May 2026
Sr One Capital Management, Llc10% ownerbought277,777at $18.001 May 2026filed 1 May 2026
Jill CarrollDirectorbought277,778at $18.001 May 2026filed 1 May 2026
Novo Holdings A/s10% ownerbought555,555at $18.001 May 2026filed 5 May 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders90
New · exited90 · 0
Reported value$1.3B

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
FMR LLCnew · filed 13 Aug 20265,835,259$192.1M+5,835,259
NOVO HOLDINGS A/Snew · filed 14 Aug 20263,883,289$127.8M+3,883,289
SR One Capital Management, LPnew · filed 12 Aug 20263,308,649$108.9M+3,308,649
PERCEPTIVE ADVISORS LLCnew · filed 14 Aug 20262,675,296$88.1M+2,675,296
MONTANOVA CAPITAL, LLCnew · filed 14 Aug 20262,503,109$82.4M+2,503,109
NVP ASSOCIATES, LLCnew · filed 7 Aug 20262,268,404$74.7M+2,268,404
WELLINGTON MANAGEMENT GROUP LLPnew · filed 14 Aug 20262,201,986$72.5M+2,201,986
Catalio Capital Management, LPnew · filed 14 Aug 20261,675,830$55.2M+1,675,830
EVENTIDE ASSET MANAGEMENT, LLCnew · filed 14 Aug 20261,375,486$45.3M+1,375,486
Bellevue Group AGnew · filed 14 Aug 20261,350,000$44.4M+1,350,000

News

No headline names it lately.

Everyone who traded it

Robert J. Meyer Company insiderDirector · last 15 Sep 20260 · 0
FMR LLC Company insider10% owner, Other · last 1 May 20260 · 0
Jill Carroll Company insiderDirector · last 1 May 20261 · 0
Novo Holdings A/S Company insider10% owner · last 1 May 20261 · 0
Simeon George Company insider10% owner · last 1 May 20261 · 0
SR ONE CAPITAL MANAGEMENT, LLC Company insider10% owner · last 1 May 20261 · 0
Wellington Biomedical Innovation Master Investors (Cayman) II L.P. Company insider10% owner · last 1 May 20260 · 0
Douglas R. Carlson Company insiderChief Financial Officer · last 30 Apr 20260 · 0
Erin Lavelle Company insiderDirector · last 30 Apr 20260 · 0
Adam H. Golden Company insiderGeneral Counsel · last 29 Apr 20260 · 0
Heather D. Turner Company insiderDirector · last 29 Apr 20260 · 0
Howard Lazarus Company insiderChief Medical Officer · last 29 Apr 20260 · 0

Same industry

No other stock in its industry this week.

Government contracts

No federal award is tied to it.

From its SEC filings

No ratio computed from its SEC filings yet.

Analyst forecasts

No analyst forecasts yet.